Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer
PTVs may assist in guiding treatment and early screening in PCa, while population-specific data for pathogenic variants are still being amassed.
Authors
- Tsai‐Jung Lu
- Yu‐Chiao Chiu (ORCID: https://orcid.org/0000-0003-1647-8634)
- Cai-Sian Liao
- Yu‐Hsuan Joni Shao (ORCID: https://orcid.org/0000-0002-0757-1901)
- Yen‐Chuan Ou (ORCID: https://orcid.org/0000-0002-6080-7231)
- Tzu-Hung Hsiao
- Yu-Ching Hsu
Institutions
- Fu Jen Catholic University (TW)
- National Chung Hsing University (TW)
- National Taiwan University (TW)
- Taipei Medical University Hospital (TW)
- Taichung Veterans General Hospital (TW)
- UPMC Hillman Cancer Center (US)
- Tungs' Taichung MetroHarbor Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1186/s12885-024-13045-4
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Technology, Taiwan
- Janssen Pharmaceuticals